Myovant Sciences and Accord Healthcare enter into exclusive licence agreement to commercialise…
Myovant to receive an upfront payment of $50 million, is eligible to receive commercial launch, sales-based and other milestones…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
prostate cancer treatment
BDR Pharma launches Bdenza 160 mg for treatment of prostate cancer
Another first time ever launch of Enzalutamide 160 mg in BDR Pharma's basket was awaited by many Indian oncologists
Bayer lifts peak sales estimate for prostate cancer drug
The company said it now expected more than 3 billion euros ($3.4 billion) in sales from the product in its best year
Dr Reddy’s Laboratories launch Abiraterone Acetate Tablets USP in the US
The drug is used for the treatment of prostate cancer